Royal Philips, a global health technology company has announced it signed a 10-year strategic partnership agreement with Rutherford Diagnostics. This collaboration will utilize Philips innovative radiology technology and Rutherford Diagnostics’ healthcare expertise to deliver and operate advanced personalized diagnostic services through a network of community diagnostic centers, driving the best possible healthcare outcomes for patients. Rutherford Diagnostics is a subsidiary of Proton Partners International which operates diagnostic and cancer centers across the United Kingdom.
Partnership Details
The agreement has a term of 10-years and the two organizations will work in partnership to deliver advanced diagnostics services, through five new diagnostics centers across the UK. Under the terms of the agreement, which is built around a Managed Technology Service, Philips will deliver: state-of-the-art imaging equipment provision; management and technology utilization reporting; continuous training; and research and innovation program.
Go-Live Timeline
Philips and Rutherford Diagnostics will help expand access to diagnostic services for local patients in a cost-effective way that supports the best possible patient outcomes and experiences. The first three community diagnostic centers are due to go live in 2020, with the remaining two in 2021. The first site is expected to welcome patients in Liverpool in 2020.
“For Philips, a successful managed service uses technology as an enabler to drive improved clinical practices and patient outcomes through innovation and sustainability,” said Stephen McMillan, Solutions Lead for Philips in the UK. “We believe this partnership with Rutherford Diagnostics is an opportunity to deliver a truly patient-centric diagnostic service with high levels of staff satisfaction. Philips already has a number of innovative managed service agreements with NHS partners here in the UK, so this is an exciting expansion of this service for us, as we partner with our first private provider.”
